Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-08-06

FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original ANDA for fosphenytoin sodium, a generic version of the anticonvulsant, manufactured by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

ORIG AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)